Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bayer AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Bayer AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Bayer AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Bayer AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Bayer AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Bayer AG, Medical Equipment, Deal Details 12
Partnerships 12
Bayer Enters into Licensing Agreement with DelSiTech 12
ChromoTek Enters Into Licensing Agreement With Bayer For Cell Cycle Chromobody Technology 13
Icagen Enters into Agreement with Bayer 14
Bayer Enters into Co-Development Agreement with Leica Biosystems 15
T2 Biosystems Enters into R&D Agreement with Bayer 16
Genedata Enters into Co-Development Agreement with Bayer Pharma 17
Orion Enters into Agreement with Bayer for Prostate Cancer Treatment 18
Ventana Extends Co-Development Agreement With Bayer Pharma 19
Bayer Yakuhin Enters Into Distribution Agreement With Femasys For FemVue Saline-Air Device 20
Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma 21
Bayer Vital Signs Agreement With Vital Images 22
Debt Offering 23
Bayer Raises USD4.3 Billion in Private Placement of Convertible Notes due 2019 23
Bayer Raises USD1.4 Billion in Public Offering of 2.375% Hybrid Bonds Due 2075 24
Bayer Prices 1.25% Bonds Due 2023 for USD623.5 Million 25
Bayer Raises USD2.38 Billion in Public Offering of 3% Bonds Due 2075 26
Bayer Raises USD2 Billion in Public Offering of 3.75% Bonds Due 2074 28
Bayer Raises USD677.3 Million in Public Offering of Notes Due 2016 30
Bayer Raises USD1.02 Billion in Public Offering of 1.125% Notes Due 2018 31
Bayer Raises USD1.02 Billion in Public Offering of 1.875% Bonds Due 2021 32
Bayer Completes Public Offering Of Notes Due 2019 For US$102 Million 33
Bayer Completes Public Offering Of Notes Due 2016 For US$259 Million 34
Bayer Holding Completes Public Offering Of 0.82% Corporate Bonds Due 2017 For US$363 Million 35
Asset Transactions 36
Bayer May Sell Radiology Business 36
Panasonic Healthcare Acquires Diabetes Care Business from Bayer for USD1.15 Billion 37
Boston Scientific Acquires Vascular Catheter Business of Bayer for USD414 Million 38
Polymer Technology Systems Acquires A1CNow From Bayer Diabetes Care 39
Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 40
Acquisition 41
Bayer May Acquire Sirtex Medical 41
Bayer Completes Acquisition Of 96.4% Stake In Conceptus For US$1.1 Billion 42
MEDRAD Completes Acquisition Of Pathway Medical Technologies For US$125 Million 44
Bayer AG – Key Competitors 46
Bayer AG – Key Employees 47
Bayer AG – Locations And Subsidiaries 50
Head Office 50
Other Locations & Subsidiaries 50
Joint Venture 59
Recent Developments 60
Strategy And Business Planning 60
Sep 20, 2016: Bayer sets ambitious growth and earnings aspirations 60
Financial Announcements 62
Oct 26, 2017: Bayer: Sales and earnings increased 62
Apr 27, 2017: Strong start to the year for Bayer 67
Apr 26, 2016: Bayer Announces Interim report for the first quarter of 2016 70
Corporate Communications 72
Nov 15, 2017: Heiko Schipper to join Bayer Board of Management and head Consumer Health Division 72
Nov 15, 2017: Heiko Schipper is the new CEO and Head of the Consumer Health Division at Bayer 73
Oct 19, 2017: Bayer Appoints Jennifer Brendel to Vice President, Head of U.S. Consumer Health Communications 74
Sep 22, 2017: Bayer Appoints Dr. Sharon James Head of Global Innovation & Development for Consumer Health 75
Sep 12, 2017: Wolfgang Nickl to be new Chief Financial Officer at Bayer 76
Sep 07, 2017: Bayer again listed in the Dow Jones Sustainability World Index 77
Jun 05, 2017: Bayer Expands Oncology Organization with Two New Leadership Team Appointments 78
May 02, 2017: Bayer Appoints Bhavesh Ashar to Lead U.S. Oncology Business 79
Apr 27, 2017: Supervisory Board of Bayer extends service contract of CFO Johannes Dietsch to the end of May 2018 80
Jan 17, 2017: Dr. Carsten Brunn to Lead Bayer’s Pharmaceuticals Business in the Americas Region 81
Apr 25, 2016: 2016 Otto Bayer Award goes to Professor Dr. Dirk Trauner 82
Mar 23, 2016: Dr. Michael Preuss to be new head of Communications at Bayer 83
Feb 24, 2016: Werner Baumann to succeed Dr. Marijn Dekkers as Chairman of the Board of Management of Bayer AG 84
Legal and Regulatory 85
Aug 22, 2017: Bayer will continue to work constructively with the European Commission 85
Government and Public Interest 86
Feb 22, 2017: Another record year for Bayer – good progress with the acquisition of Monsanto 86
Product News 90
02/29/2016: FDA takes additional action to better understand safety of Essure, inform patients of potential risks 90
Other Significant Developments 92
Jul 27, 2016: Bayer raises sales and earnings 92
Appendix 95
Methodology 95
About GlobalData 95
Contact Us 95
Disclaimer 95
Bayer AG, Medical Equipment, Key Facts, 2016 2
Bayer AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Bayer AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Bayer AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Bayer AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Bayer AG, Deals By Market, 2011 to YTD 2017 9
Bayer AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Bayer Enters into Licensing Agreement with DelSiTech 12
ChromoTek Enters Into Licensing Agreement With Bayer For Cell Cycle Chromobody Technology 13
Icagen Enters into Agreement with Bayer 14
Bayer Enters into Co-Development Agreement with Leica Biosystems 15
T2 Biosystems Enters into R&D Agreement with Bayer 16
Genedata Enters into Co-Development Agreement with Bayer Pharma 17
Orion Enters into Agreement with Bayer for Prostate Cancer Treatment 18
Ventana Extends Co-Development Agreement With Bayer Pharma 19
Bayer Yakuhin Enters Into Distribution Agreement With Femasys For FemVue Saline-Air Device 20
Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma 21
Bayer Vital Signs Agreement With Vital Images 22
Bayer Raises USD4.3 Billion in Private Placement of Convertible Notes due 2019 23
Bayer Raises USD1.4 Billion in Public Offering of 2.375% Hybrid Bonds Due 2075 24
Bayer Prices 1.25% Bonds Due 2023 for USD623.5 Million 25
Bayer Raises USD2.38 Billion in Public Offering of 3% Bonds Due 2075 26
Bayer Raises USD2 Billion in Public Offering of 3.75% Bonds Due 2074 28
Bayer Raises USD677.3 Million in Public Offering of Notes Due 2016 30
Bayer Raises USD1.02 Billion in Public Offering of 1.125% Notes Due 2018 31
Bayer Raises USD1.02 Billion in Public Offering of 1.875% Bonds Due 2021 32
Bayer Completes Public Offering Of Notes Due 2019 For US$102 Million 33
Bayer Completes Public Offering Of Notes Due 2016 For US$259 Million 34
Bayer Holding Completes Public Offering Of 0.82% Corporate Bonds Due 2017 For US$363 Million 35
Bayer May Sell Radiology Business 36
Panasonic Healthcare Acquires Diabetes Care Business from Bayer for USD1.15 Billion 37
Boston Scientific Acquires Vascular Catheter Business of Bayer for USD414 Million 38
Polymer Technology Systems Acquires A1CNow From Bayer Diabetes Care 39
Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 40
Bayer May Acquire Sirtex Medical 41
Bayer Completes Acquisition Of 96.4% Stake In Conceptus For US$1.1 Billion 42
MEDRAD Completes Acquisition Of Pathway Medical Technologies For US$125 Million 44
Bayer AG, Key Competitors 46
Bayer AG, Key Employees 47
Bayer AG, Subsidiaries 50
Bayer AG, Joint Venture 59
